JA, P., JL, L., GM, T., TA, W., AJ, N., MJ, D., . . . TR, M. (2026). Blocking interleukin 33 reduces joint, systemic, and lung inflammatory responses in the combined collagen-induced arthritis-inhalant endotoxin exposure model. The Journal of pharmacology and experimental therapeutics, 104983. https://doi.org/10.1016/j.jpet.2026.104983
Chicago Style (17th ed.) CitationJA, Poole, et al. "Blocking Interleukin 33 Reduces Joint, Systemic, and Lung Inflammatory Responses in the Combined Collagen-induced Arthritis-inhalant Endotoxin Exposure Model." The Journal of Pharmacology and Experimental Therapeutics 2026: 104983. https://doi.org/10.1016/j.jpet.2026.104983.
MLA (9th ed.) CitationJA, Poole, et al. "Blocking Interleukin 33 Reduces Joint, Systemic, and Lung Inflammatory Responses in the Combined Collagen-induced Arthritis-inhalant Endotoxin Exposure Model." The Journal of Pharmacology and Experimental Therapeutics, 2026, p. 104983, https://doi.org/10.1016/j.jpet.2026.104983.